4.8 Article

Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Microbiology

Long COVID: major findings, mechanisms and recommendations

Hannah E. Davis et al.

Summary: Long COVID is a common and debilitating illness that affects at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, with a wide range of symptoms and impacts on multiple organ systems. There are an estimated 65 million individuals worldwide with long COVID, and the number of cases is increasing daily. Current diagnostic and treatment options are insufficient, and there is a need for clinical trials to address leading hypotheses. Future research should account for biases and testing issues, build on viral-onset research, include marginalized populations, and meaningfully engage patients.

NATURE REVIEWS MICROBIOLOGY (2023)

Article Computer Science, Information Systems

Synergies between centralized and federated approaches to data quality: a report from the national COVID cohort collaborative

Emily R. Pfaff et al.

Summary: The informatics community collaborated to aggregate clinical data, resulting in the N3C dataset, which revealed and improved data quality issues across 56 data partners, supporting enhanced research analytics locally and in aggregate.

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2022)

Review Infectious Diseases

A clinical case definition of post-COVID-19 condition by a Delphi consensus

Joan B. Soriano et al.

Summary: People with COVID-19 might experience long-term symptoms known as long COVID or long-haul COVID. The lack of a standardized definition hinders the understanding and treatment of this condition. In a WHO-led Delphi process, a consensus definition was developed, stating that post-COVID-19 condition occurs in individuals with a history of SARS-CoV-2 infection, with symptoms lasting for at least 2 months and impacting everyday functioning. This common framework provides a foundation for future studies and therapy.

LANCET INFECTIOUS DISEASES (2022)

Article Immunology

Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study

Marc Scherlinger et al.

Summary: This study suggests that SARS-CoV-2 vaccination is well tolerated and immunogenic in the majority of patients with long-COVID or post-acute sequelae of COVID-19 (PASC). Disseminating these reassuring data might prove crucial to increasing vaccine coverage in patients with PASC.

VACCINES (2022)

Article Immunology

Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States

Mark W. Tenforde et al.

Summary: From March to May 2021, full vaccination using authorized mRNA products was associated with 87.1% protection against COVID-19 hospitalization among US adults, with lower effectiveness in adults with immunosuppression compared to those without. Vaccination was beneficial for patients with immunosuppression, but the effectiveness was lower in this population.

CLINICAL INFECTIOUS DISEASES (2022)

Article Health Care Sciences & Services

Association of Vaccination with the Persistence of Post-COVID Symptoms

Juan P. Wisnivesky et al.

Summary: This study examined the differences in post-acute sequelae of COVID (PASC) between vaccinated and unvaccinated patients. The findings suggest that COVID vaccination is not associated with improvement in PASC.

JOURNAL OF GENERAL INTERNAL MEDICINE (2022)

Article Infectious Diseases

COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study

Cristina Menni et al.

Summary: This study aimed to investigate the effectiveness and waning of COVID-19 primary vaccine series, as well as the safety and effectiveness of booster doses. The results showed that vaccine effectiveness decreased after the second dose, but booster doses restored effectiveness. However, heterologous booster regimens had more systemic side-effects.

LANCET INFECTIOUS DISEASES (2022)

Article Biochemistry & Molecular Biology

Long COVID after breakthrough SARS-CoV-2 infection

Ziyad Al-Aly et al.

Summary: This study analyzed the US Department of Veterans Affairs national healthcare databases to investigate the occurrence of Long COVID and death risk after breakthrough SARS-CoV-2 infection. The findings showed that vaccination significantly reduced the risk of death and post-acute sequelae but did not eliminate them completely. These results underscore the importance of further research on prevention and post-acute care for breakthrough infections.

NATURE MEDICINE (2022)

Article Medicine, General & Internal

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

Adam S. Lauring et al.

Summary: mRNA vaccines were highly effective in preventing covid-19 associated hospital admissions related to the alpha, delta, and omicron variants. Three vaccine doses were required for protection against omicron, while two doses provided protection against delta and alpha variants. Omicron variant showed lower disease severity compared to delta variant but still resulted in morbidity and mortality. Vaccinated patients had lower disease severity than unvaccinated patients for all the variants.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Article Immunology

The Protective Effect of Coronavirus Disease 2019 (COVID-19) Vaccination on Postacute Sequelae of COVID-19: A Multicenter Study From a Large National Health Research Network

Sokratis N. Zisis et al.

Summary: This study suggests that COVID-19 vaccine is protective against mortality and each incident postacute sequelae of coronavirus disease 2019 (PASC) outcome. In addition, vaccination is associated with a significantly lower likelihood of experiencing new or persistent PASC symptoms.

OPEN FORUM INFECTIOUS DISEASES (2022)

Article Multidisciplinary Sciences

Characteristics and predictors of Long COVID among diagnosed cases of COVID-19

M. C. Arjun et al.

Summary: This study estimated the incidence of long COVID among patients and identified predictors. The results showed a high incidence of long COVID, which was associated with pre-existing medical conditions, number of symptoms, COVID-19 vaccination, severity of illness, and hospitalization.

PLOS ONE (2022)

Article Immunology

Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections

Maxime Taquet et al.

Summary: Vaccination against COVID-19 has been shown to reduce the risk of certain outcomes following SARS-CoV-2 infection, but not all outcomes. The age and number of vaccine doses may have an impact on the effectiveness of the vaccine.

BRAIN BEHAVIOR AND IMMUNITY (2022)

Letter Medicine, General & Internal

Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2

Michela Antonelli et al.

LANCET (2022)

Article Immunology

The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study

Elke Wynberg et al.

Summary: A prospective study found that vaccination did not significantly improve symptoms in patients with PASC, and there was no difference in antibody decay rates between PASC and non-PASC patients.

VACCINE (2022)

Article Immunology

Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study

Daniel Ayoubkhani et al.

Summary: Vaccination reduces the incidence of long COVID, highlighting the importance of increasing population-level vaccine uptake through public health initiatives.

OPEN FORUM INFECTIOUS DISEASES (2022)

Article Medical Informatics

Identifying who has long COVID in the USA: a machine learning approach using N3C data

Emily R. Pfaff et al.

Summary: Long COVID has had a severe impact on patient and societal recovery from the COVID-19 pandemic. This study developed machine learning models to accurately identify potential long COVID patients using electronic health records. Important features in identifying long COVID included healthcare utilization rate, patient age, dyspnea, and other diagnosis and medication information.

LANCET DIGITAL HEALTH (2022)

Article Medicine, General & Internal

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)

Chaolin Huang et al.

Summary: This study aimed to investigate the long-term health consequences of discharged COVID-19 patients and associated risk factors, particularly disease severity. Patients with more severe illness during hospitalization showed more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, highlighting the need for targeted interventions for long-term recovery.

LANCET (2021)

Editorial Material Medicine, General & Internal

Toward Understanding COVID-19 Recovery: National Institutes of Health Workshop on Postacute COVID-19

Andrea M. Lerner et al.

Summary: The SARS-CoV-2 pandemic has caused a massive global burden of infection and mortality over the past year, with additional tolls from long-term consequences yet to be quantified. A virtual workshop was held in December 2020 to discuss postacute COVID-19 and identify key knowledge gaps in understanding this condition, which includes heterogeneous disease manifestations among some individuals even after their initial recovery from acute SARS-CoV-2 infection.

ANNALS OF INTERNAL MEDICINE (2021)

Article Medicine, General & Internal

Characterizing Long COVID: Deep Phenotype of a Complex Condition

Rachel R. Deer et al.

EBIOMEDICINE (2021)

Letter Medicine, General & Internal

Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers

Sebastian Havervall et al.

Summary: This study found that COVID-19-related symptoms can persist for 8 months among Swedish health care workers, and these symptoms have effects on their home, work, and social functions.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Multidisciplinary Sciences

More than 50 long-term effects of COVID-19: a systematic review and meta-analysis

Sandra Lopez-Leon et al.

Summary: This study aimed to identify studies assessing the long-term effects of COVID-19, estimating that 80% of infected patients will develop one or more long-term symptoms, with the most common being fatigue, headache, attention disorder, hair loss, and dyspnea.

SCIENTIFIC REPORTS (2021)

Review Medicine, General & Internal

Long covid-mechanisms, risk factors, and management

Harry Crook et al.

Summary: The long-term effects of covid-19 can affect multiple systems in the body, leading to persistent symptoms that impact patients of varying severity. These symptoms include fatigue, dyspnea, and cognitive impairment, among others. Studies discuss risk factors for acute and long covid, as well as potential therapeutic options.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Computer Science, Information Systems

The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment

Melissa A. Haendel et al.

Summary: N3C is an open science community focused on analyzing patient-level data from multiple centers to address the challenges posed by COVID-19. By overcoming technical, regulatory, policy, and governance barriers, N3C has successfully established a secure data enclave for efficient, transparent, and reproducible collaborative analytics.

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2021)

Article Public, Environmental & Occupational Health

Measurement Error and Misclassification in Electronic Medical Records: Methods to Mitigate Bias

Jessica C. Young et al.

CURRENT EPIDEMIOLOGY REPORTS (2018)

Article Public, Environmental & Occupational Health

Controlling for Informed Presence Bias Due to the Number of Health Encounters in an Electronic Health Record

Benjamin A. Goldstein et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)

Article Computer Science, Information Systems

PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability

Jacqueline C. Kirby et al.

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2016)

Article Mathematical & Computational Biology

Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis

Peter C. Austin

STATISTICS IN MEDICINE (2016)

Article Political Science

Reassessing Schoenfeld Residual Tests of Proportional Hazards in Political Science Event History Analyses

Sunhee Park et al.

AMERICAN JOURNAL OF POLITICAL SCIENCE (2015)

Article Medicine, General & Internal

Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership

Paul E. Stang et al.

ANNALS OF INTERNAL MEDICINE (2010)

Article Public, Environmental & Occupational Health

Overadjustment Bias and Unnecessary Adjustment in Epidemiologic Studies

Enrique F. Schisterman et al.

EPIDEMIOLOGY (2009)

Article Public, Environmental & Occupational Health

Constructing inverse probability weights for marginal structural models

Stephen R. Cole et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)

Article Public, Environmental & Occupational Health

Age and gender differences in health service utilization

J Keene et al.

JOURNAL OF PUBLIC HEALTH (2005)

Review Nursing

Men and health help-seeking behaviour: literature review

PM Galdas et al.

JOURNAL OF ADVANCED NURSING (2005)

Article Public, Environmental & Occupational Health

Marginal structural models and causal inference in epidemiology

JM Robins et al.

EPIDEMIOLOGY (2000)